TPST Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Tempest Therapeutics Inc (TPST) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. The stock shows no strong technical or fundamental support for a long-term investment, and there are no significant catalysts or positive financial trends to justify a buy decision at this time.
The MACD is slightly positive at 0.0166 but contracting, indicating weakening momentum. The RSI is neutral at 41.17, and moving averages are converging, showing no clear trend. Key support and resistance levels suggest the stock is trading near support at 1.688, with resistance at 2.021. Overall, the technical indicators do not provide a strong buy signal.
NULL identified. No recent news or significant insider or hedge fund activity. No recent congress trading data.
Revenue remains at 0, with no growth. Additionally, the stock has a 40% chance of minor gains in the next week but a higher likelihood of losses in the next month (-2.73%).
In Q4 2025, revenue remained at 0 with no YoY growth. Net income dropped significantly to -$4,021,000 (-70.89% YoY), and EPS fell to -0.82 (-81.28% YoY). Gross margin remains at 0 with no improvement.
No recent analyst ratings or price target changes are available.
